7384-16-9 Usage
Description
3-HYDROXY-4-NITRO (1H)INDAZOLE is a synthetic organic chemical compound that belongs to the indazole family. It has a molecular formula of C8H6N4O3 and is classified as a nitrobenzene derivative. 3-HYDROXY-4-NITRO (1H)INDAZOLE features both a nitro group and a hydroxyl group, making it a versatile building block in the pharmaceutical industry for the synthesis of various drugs and organic compounds. Additionally, it has been studied for its potential biological activities, such as anti-cancer and anti-inflammatory properties.
Uses
Used in Pharmaceutical Industry:
3-HYDROXY-4-NITRO (1H)INDAZOLE is used as a building block for the synthesis of various drugs and organic compounds. Its unique structure and functional groups make it a valuable component in the development of new pharmaceutical agents.
Used in Medicinal Chemistry Research:
3-HYDROXY-4-NITRO (1H)INDAZOLE is used as a starting material in the design and synthesis of novel compounds with potential therapeutic applications. Its chemical properties allow for further modification and functionalization, enabling the exploration of new drug candidates with improved efficacy and safety profiles.
Used in Biological Activity Studies:
3-HYDROXY-4-NITRO (1H)INDAZOLE is used in research to investigate its potential biological activities, such as anti-cancer and anti-inflammatory properties. These studies aim to understand the compound's mechanism of action and its potential use in the treatment of various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 7384-16-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,8 and 4 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7384-16:
(6*7)+(5*3)+(4*8)+(3*4)+(2*1)+(1*6)=109
109 % 10 = 9
So 7384-16-9 is a valid CAS Registry Number.
7384-16-9Relevant articles and documents
2,4-DI(AMINOPHENYL) PYRIMIDINES AS PLK INHIBITORS
-
Page/Page column 32, (2008/06/13)
The invention relates to compounds of general formula (1), wherein A, W, X, Y, Z, Ra, Rb, Rc, R1, and R3 are defined as indicated in claim 1. Said compounds are used for the treatment of diseases characterized by excessive or anomalous cell proliferation. Also disclosed is the use of the inventive compounds for producing a medicament having said properties.
